BMC Women's Health is a premier, open-access journal published by BMC, dedicated to advancing the understanding and knowledge of women's health issues across a broad spectrum of scientific and clinical disciplines. Since its inception in 2001, the journal has established itself as a crucial platform for researchers and healthcare professionals, focusing on interdisciplinary studies that span obstetrics, gynecology, and reproductive medicine. With an impact factor reflected in its ranking within the second quartile (Q2) in Medicine (miscellaneous), Obstetrics and Gynecology, and Reproductive Medicine categories for 2023, BMC Women's Health effectively bridges the gap between research and practice, promoting innovative findings with global relevance. The journal's open-access model ensures unhindered access to high-quality articles, encouraging the dissemination of knowledge and fostering advancements in women's health. Situated in the UK, this journal not only showcases cutting-edge research but also advocates for improved health outcomes for women worldwide. Researchers, professionals, and students alike will find BMC Women's Health to be an invaluable resource for the latest insights and trends in this vital field.

International Journal of Feminist Approaches To Bioethics, published by University of Toronto Press Inc., is a leading interdisciplinary journal dedicated to advancing the discourse on bioethics through the lens of feminist theory. Since its inception in 2012, the journal has significantly contributed to the fields of Gender Studies, Health (social science), and Philosophy, earning commendable rankings in Scopus—particularly within the realms of Arts and Humanities and Social Sciences. The journal is recognized for its rigorous peer-review process and its focus on critical, intersectional analyses, making it an essential resource for researchers, professionals, and students interested in the ethical implications of biomedical practices and policies. Although currently not an open-access publication, it offers valuable insights that challenge traditional bioethical paradigms and encourages innovative scholarship. With a dynamic scope that continues to evolve until 2024, the journal remains vital for those striving to understand the complex interplay between gender and bioethical issues.

BMJ Sexual & Reproductive Health is a premier academic journal published by the esteemed BMJ Publishing Group in the United Kingdom. With an ISSN of 2515-1991 and E-ISSN of 2515-2009, this journal stands at the forefront of critical research in the fields of Obstetrics and Gynecology and Reproductive Medicine, reflecting its commitment to delivering high-quality, peer-reviewed content. Recognized for its significant impact, the journal holds a Q1 classification in both disciplines for 2023, with Scopus rankings of 49th in Obstetrics and Gynecology and 26th in Reproductive Medicine, placing it within the top quartiles of these fields. The journal aims to bridge the gap between cutting-edge research and practical application, providing a platform for researchers, professionals, and students to engage with groundbreaking findings and stay updated on best practices in sexual and reproductive health. As an Open Access journal, it ensures that knowledge is freely available to a global audience, further promoting the advancement of science and health care practices.

WOMEN'S HEALTH ISSUES, published by Elsevier Science Inc, stands as a premier journal within the realm of women’s health research, offering a vital platform for the dissemination of cutting-edge studies. As an influential publication with an impressive reputation, it encompasses critical areas such as social sciences, maternity and midwifery, obstetrics and gynecology, and public health. With a remarkable Q1 ranking across various categories in 2023, including Nursing, Maternity and Midwifery and Obstetrics and Gynecology, this journal is recognized for its substantial impact on advancing knowledge in women's health issues. Researchers and healthcare professionals will find valuable insights and empirical studies that inform practice and policy. Although the journal is not Open Access, it provides a wealth of information originating from rigorous research and expert reviews aimed at enhancing women’s health outcomes. To explore a comprehensive range of topics, this journal spans a convergence period from 1990 to 2024, continually evolving with the field's advancements.

STUDIES IN FAMILY PLANNING, published by WILEY, is a renowned journal that serves as a critical resource in the fields of Demography and Social Sciences. With an impressive Q1 ranking in both categories, it is recognized for its high impact and influential contributions to the understanding of family planning dynamics, reproductive health, and population studies. The journal has published scholarly articles since 1970, reflecting its long-standing commitment to advancing knowledge and research in these important areas. Currently holding a rank of #27 out of 139 in Demography on Scopus, the journal's 2023 impact factor underscores its influential role in shaping policy and practice worldwide. Though it operates under a subscription model, it is readily accessible to members of the academic community, including researchers, professionals, and students dedicated to improving family planning systems and socio-demographic studies.

Reproductive Health is a leading open-access journal published by BMC, dedicated to advancing knowledge in the fields of obstetrics, gynecology, and reproductive medicine. Established in 2004, the journal has made significant contributions to the global discourse on reproductive health practices and policies, garnering a prestigious Q1 rank in both the Obstetrics and Gynecology and Reproductive Medicine categories as of 2023. With a strong Scopus ranking of #36 out of 209 in Obstetrics and Gynecology and #20 out of 90 in Reproductive Medicine, it boasts an impressive reach and impact, ensuring that vital research is accessible to a wide audience. Reproductive Health aims to foster innovative research and practice, facilitating a deeper understanding of reproductive health issues that affect diverse populations. As an open-access journal, it ensures that all research outputs are freely available, promoting transparency and collaboration in the scientific community. Based in the United Kingdom, Reproductive Health is poised to continue its mission of enhancing reproductive health outcomes worldwide through rigorous research, clinical trials, and public health studies.

CONTRACEPTION is a leading academic journal dedicated to advancing the field of reproductive health, published by Elsevier Science Inc. Since its inception in 1970, the journal has consistently provided a platform for high-quality research and insights in both Obstetrics and Gynecology and Reproductive Medicine, achieving notable recognition as a Q1 journal in these categories as of 2023. With an impact factor that underscores its significance—ranked #57 out of 209 in Obstetrics and Gynecology and #28 out of 90 in Reproductive Medicine according to Scopus—CONTRACEPTION is essential reading for researchers, clinicians, and students alike. The journal is committed to publishing innovative studies, review articles, and evidence-based guidelines that inform clinical practice and enhance patient care. Although it does not currently offer open access options, its comprehensive coverage of contemporary issues and empirical data makes it an invaluable resource for those invested in the future of reproductive healthcare.

The Journal of Obstetrics and Gynaecology Canada, published by Elsevier Inc., is a leading bi-monthly journal committed to advancing the fields of obstetrics and gynecology through high-quality research and clinical insights. With an impact factor positioned within the competitive Q2 category of the Obstetrics and Gynecology field as of 2023, this journal serves as a vital resource for researchers, clinicians, and students eager to stay informed about the latest developments. The journal is renowned for its rigorous peer-review process and dedication to disseminating innovative findings from 2002 to 2024. Currently ranked #92 out of 209 in Scopus' Medicine Obstetrics and Gynecology category, it falls within the 56th percentile of its peers. While it operates on a subscription basis, the contents are pivotal for professionals looking to enhance their practices and contribute to the ongoing discourse in maternal and women's health. For those dedicated to improving patient outcomes and advancing gynecological knowledge, the Journal of Obstetrics and Gynaecology Canada represents an invaluable platform.

Taiwanese Journal of Obstetrics & Gynecology, published by Elsevier Taiwan, stands as a leading platform in the field of obstetrics and gynecology, fostering academic discourse and innovative research since its inception in 2004. With an impact factor that places it in the Q2 category of its field, it ranks #84 out of 209 journals in Obstetrics and Gynecology according to Scopus, indicating a significant reputation within the medical community. This open access journal ensures wide dissemination of research findings, allowing professionals, researchers, and students alike to stay updated with the latest advancements and practices. The journal's focus on publishing high-quality, peer-reviewed articles covers a broad range of topics within the field, making it an essential resource for those interested in women's health issues, clinical practices, and medical advancements in Taiwan and beyond. With its commitment to excellence, the Taiwanese Journal of Obstetrics & Gynecology invites contributions that enhance the understanding and management of obstetric and gynecological care.

Contraception and Reproductive Medicine is a prestigious open-access journal published by BMC that has been serving the global community since 2016. With a focus on the latest research and advancements in the fields of contraception and reproductive health, this journal aims to address the challenges and innovations in fertility management, women's health, and sexual education. As an Open Access platform, it provides researchers, professionals, and students unrestricted access to high-quality, peer-reviewed articles, facilitating the dissemination of vital knowledge and findings. Although specific metrics like the impact factor and H-index are unavailable, the journal's commitment to fostering a vibrant academic dialogue ensures it remains an influential resource in reproductive medicine. Located in London, England, Contraception and Reproductive Medicine invites contributions that highlight both clinical practices and policy implications, ultimately aiming to improve reproductive health care worldwide.